ArchPoint Investors’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.37M Buy
203,500
+4,500
+2% +$173K 1.76% 15
2025
Q4
$7.65M Hold
199,000
1.82% 15
2025
Q3
$7.22M Hold
199,000
1.98% 12
2025
Q2
$6.82M Buy
199,000
+31,000
+18% +$983K 2% 13
2025
Q1
$5.26M Buy
168,000
+46,000
+38% +$1.5M 1.73% 17
2024
Q4
$3.9M Hold
122,000
1.28% 18
2024
Q3
$3.99M Hold
122,000
1.33% 18
2024
Q2
$3.79M Buy
+122,000
New +$3.63M 1.42% 20

Other funds holding QLTY

ArchPoint Investors's QLTY Position: Q1 2026 in Review

ArchPoint Investors increased its GMO US Quality ETF (QLTY) stake by 2.3% in Q1 2026, buying an estimated $173K and bringing the position to 203,500 shares worth $7.37M. The position accounts for 1.76% of the portfolio, ranked #15.

ArchPoint Investors first reported a position in QLTY in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.65M in Q4 2025. 149 funds tracked by Wall St. Rank hold QLTY as of Q1 2026.

  • ArchPoint Investors held 203,500 shares of GMO US Quality ETF worth $7.37M as of Q1 2026.
  • ArchPoint Investors bought 4,500 GMO US Quality ETF shares in Q1 2026, an estimated $173K.
  • GMO US Quality ETF made up 1.76% of ArchPoint Investors's portfolio in Q1 2026, its #15 holding.
  • ArchPoint Investors first reported a position in GMO US Quality ETF in Q2 2024 and has held it in 8 quarters since.
  • ArchPoint Investors's GMO US Quality ETF position peaked at $7.65M in Q4 2025.
  • 149 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q1 2026.

Based on ArchPoint Investors's 13F filing for Q1 2026, filed 14 May 2026.